Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology Brothers
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe
Advertisement

Fatigue Is Strongest Cancer-Related Side Effect, Survey Shows

February 1, 1999
Publication
Article
OncologyONCOLOGY Vol 13 No 2
Volume 13
Issue 2

Findings released from a national survey underscore what cancer patients already know: The fatigue following chemotherapy treatment has a sweeping impact on patients’ physical and emotional health, as well as their economic well-being.

Findings released from a national survey underscore what cancer patients already know: The fatigue following chemotherapy treatment has a sweeping impact on patients’ physical and emotional health, as well as their economic well-being.

Three-quarters (76%) of the 379 cancer patients surveyed consistently experienced fatigue, and nearly 9 (89%) out of 10 of those who experienced fatigue said that cancer fatigue, commonly caused by chemotherapy-induced anemia, interferes with their normal daily life.

Survey Highlights

The survey included patients who had been treated for cancers of the breast, prostate, lung, or skin, as well as those with leukemia or lymphoma. The following are highlights of the survey results from the 301 patients who experienced fatigue:

Among fatigued patients, 60% reported that fatigue affects their lives more than any other side effect of cancer, including nausea (22%), pain (6%), and depression (10%).

Fatigue was the longest-lasting side effect of cancer treatment. Close to half of patients (45%) experienced fatigue for at least 1 week after chemotherapy and 33% had fatigue that lasted 2 weeks or more after chemotherapy.

Among fatigued patients, 89% said that fatigue changed the way that they go about their normal daily life, and a majority said the condition causes distress and interferes with daily activities.

Patients said that fatigue affects their ability to earn a living: Among employed patients, 71% missed one or more days of work per month and 31% missed nearly an entire week. Similarly, their caregivers took off about the same number of days to help care for them. Another 28% said fatigue forced them to stop working altogether. Three-fourths (75%) of patients had to change their work habits, such as cutting hours at work or taking on less responsibility.

The impact of fatigue on family/social life was equally dramatic, as 59% of respondents said that they had difficulty socializing with family or friends; 52% said that they couldn’t meet the needs of their family or loved ones; 37% cited problems maintaining interpersonal relationships; 30% had difficulty being intimate with their partner; and 25% felt distant from family members and friends.

Fatigue also interferes with an individual’s ability to perform normal everyday tasks. A majority of respondents said that cancer fatigue interfered with daily activities, such as cleaning the house (69%), running errands (56%), climbing stairs (56%), and walking distances (69%).

Patients are largely misinformed about cancer fatigue, and physicians do not always provide them with the information they need. Among the fatigued patients, 61% assumed that the condition would disappear on its own; 45% believed that there was nothing their physician could do to treat cancer-related fatigue; and 25% said that their physicians did not explain the causes and treatments of the condition.

One-third (32%) of fatigued patients said that they had been diagnosed with anemia, a common cause of fatigue. Despite this, only 9% of fatigued patients were treated with prescription drugs or transfusions to correct the condition.

Common Causes of Fatigue

“The survey results confirm that the debilitating fatigue during cancer treatment is seriously underrecognized and undertreated,” said Gregory A. Curt, MD, of the National Cancer Institute and a member of the Fatigue Coalition. “The physical, emotional and economic stress of fatigue on cancer patients has a serious impact on their ability to get back to the business of living.”

The most common cause of cancer-related fatigue is anemia.

Treatment Options

“The real message of the survey findings is that many patients with fatigue are suffering alone when treatment options are available. Clearly, based on these results, fatigue may jeopardize patients’ careers and their ability to take care of themselves and their families. The treatment community and patients need to recognize this fact and actively seek and request more treatment options,” said Susan L. Scherr, a cancer survivor who is a member of the Fatigue Coalition and serves as director of community and strategic alliances for the National Coalition for Cancer Survivorship (NCCS), a national advocacy group for cancer patients.

“Now, when our patients describe the way fatigue is impacting their ability to go about their daily lives, we need to evaluate each individual’s condition and treat fatigue aggressively when needed,” added Dr. Curt.

Articles in this issue

High-Dose Cytarabine Produces High Cure Rate in Some AML Patients
A Primer on BMT for New Transplant Nurses
What BMT Nurses Should Know About Insurance Issues
Fewer Complications With Modified Radical Surgery of the Vulva
ONS Guidelines on Office-Based Clinical Trials
New Web Site Fills Need for Reliable Cancer Information
Fatigue Is Strongest Cancer-Related Side Effect, Survey Shows
Complementary Treatments Highlighted at Recent Meeting
Alternatives to Oral Opioids for Cancer Pain
Alternatives to Oral Opioids for Cancer Pain
Molecular Staging of Prostate Cancer: Dream or Reality?
Molecular Staging of Prostate Cancer: Dream or Reality?
Molecular Staging of Prostate Cancer: Dream or Reality?
Molecular Staging of Prostate Cancer: Dream or Reality?
Treatment of Estrogen Deficiency Symptoms in Women Surviving Breast Cancer, Part 2
Recent Videos
Acupuncture
Related Content
Advertisement

Complete responses were numerically higher without significance in standard triple antiemetic therapy with olanzapine vs placebo.

Adding Olanzapine to Antiemetic Therapy May Help With CINV Incidence

Roman Fabbricatore
August 4th 2024
Article

Complete responses were numerically higher without significance in standard triple antiemetic therapy with olanzapine vs placebo.


Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, discusses how nursling-led palliative care may improve advanced cancer care planning uptake based on a secondary analysis of the CONNECT study.

Oncology On-The-Go Podcast: Nursing-Led Palliative Care in Advanced Cancer

Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN
May 15th 2023
Podcast

Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, discusses how nursling-led palliative care may improve advanced cancer care planning uptake based on a secondary analysis of the CONNECT study.


Incorporating nursing-led palliative care may help to improve advanced care planning among those with advanced cancer, especially those without access to specialty palliative care.

Nursing-Led Palliative Cancer Care May Improve Advanced Care Planning

Hayley Virgil
April 13th 2023
Article

Incorporating nursing-led palliative care may help to improve advanced care planning among those with advanced cancer, especially those without access to specialty palliative care.


Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology

Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology

Dori Beeler, PhD;Xin Shelley Wang, MD, MPH;Viraj A. Master, MD, PhD
September 20th 2022
Podcast

Authors Dori Beeler, PhD; Shelley Wang, MD, MPH; and Viraj A. Master, MD, PhD, spoke with CancerNetwork® about a review article on cancer-related fatigue published in the journal ONCOLOGY®.


Initial Data on Palliative 177Lu-FAP-2286 Highlights High Uptake and Prolonged Retention Across Several Adenocarcinomas

Initial Data on Palliative 177Lu-FAP-2286 Highlights High Uptake and Prolonged Retention Across Several Adenocarcinomas

Matthew Fowler
August 24th 2021
Article

Positive preliminary data on FAP-2286 linked to the radionuclide lutetium-177 across a diverse array of adenocarcinomas was reported from the phase 1/2 LuMIERE trial.


Qualitative Study Shares Strategies for Successful End of Life Conversations for Patients With Cancer

Qualitative Study Shares Strategies for Successful End of Life Conversations for Patients With Cancer

Ariana Pelosci
August 6th 2021
Article

Trends towards missing key moments for end-of-life discussions when meeting with patients who have stage IV cancer can be overcome with existing strategies for successful EOL conversations.

Related Content
Advertisement

Complete responses were numerically higher without significance in standard triple antiemetic therapy with olanzapine vs placebo.

Adding Olanzapine to Antiemetic Therapy May Help With CINV Incidence

Roman Fabbricatore
August 4th 2024
Article

Complete responses were numerically higher without significance in standard triple antiemetic therapy with olanzapine vs placebo.


Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, discusses how nursling-led palliative care may improve advanced cancer care planning uptake based on a secondary analysis of the CONNECT study.

Oncology On-The-Go Podcast: Nursing-Led Palliative Care in Advanced Cancer

Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN
May 15th 2023
Podcast

Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, discusses how nursling-led palliative care may improve advanced cancer care planning uptake based on a secondary analysis of the CONNECT study.


Incorporating nursing-led palliative care may help to improve advanced care planning among those with advanced cancer, especially those without access to specialty palliative care.

Nursing-Led Palliative Cancer Care May Improve Advanced Care Planning

Hayley Virgil
April 13th 2023
Article

Incorporating nursing-led palliative care may help to improve advanced care planning among those with advanced cancer, especially those without access to specialty palliative care.


Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology

Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology

Dori Beeler, PhD;Xin Shelley Wang, MD, MPH;Viraj A. Master, MD, PhD
September 20th 2022
Podcast

Authors Dori Beeler, PhD; Shelley Wang, MD, MPH; and Viraj A. Master, MD, PhD, spoke with CancerNetwork® about a review article on cancer-related fatigue published in the journal ONCOLOGY®.


Initial Data on Palliative 177Lu-FAP-2286 Highlights High Uptake and Prolonged Retention Across Several Adenocarcinomas

Initial Data on Palliative 177Lu-FAP-2286 Highlights High Uptake and Prolonged Retention Across Several Adenocarcinomas

Matthew Fowler
August 24th 2021
Article

Positive preliminary data on FAP-2286 linked to the radionuclide lutetium-177 across a diverse array of adenocarcinomas was reported from the phase 1/2 LuMIERE trial.


Qualitative Study Shares Strategies for Successful End of Life Conversations for Patients With Cancer

Qualitative Study Shares Strategies for Successful End of Life Conversations for Patients With Cancer

Ariana Pelosci
August 6th 2021
Article

Trends towards missing key moments for end-of-life discussions when meeting with patients who have stage IV cancer can be overcome with existing strategies for successful EOL conversations.

Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.